The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $193.03

Today's change-2.42 -1.24%
Updated September 4 2:33 PM EDT. Delayed by at least 15 minutes.
 

Illumina Inc

Nasdaq: ILMN
Last

(U.S.) $193.03

Today's change-2.42 -1.24%
Updated September 4 2:33 PM EDT. Delayed by at least 15 minutes.

Illumina Inc down (U.S.)$2.42

Illumina Inc is lower today, dropping (U.S.)$2.42 or 1.24% to (U.S.)$193.03. Shares have lost 4.30% over the last five days, but have gained 4.58% over the last year to date. This security has outperformed the S&P 500 by 13.19% during the last year.

Key company metrics

  • Open(U.S.) $192.63
  • Previous close(U.S.) $195.45
  • High(U.S.) $195.24
  • Low(U.S.) $191.50
  • Bid / Ask(U.S.) $192.94 / (U.S.) $193.15
  • YTD % change+4.58%
  • Volume486,007
  • Average volume (10-day)1,530,032
  • Average volume (1-month)1,408,170
  • Average volume (3-month)1,465,611
  • 52-week range(U.S.) $145.12 to (U.S.) $242.37
  • Beta0.98
  • Trailing P/E59.02×
  • P/E 1 year forward56.46×
  • Forward PEG2.68×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $3.27
Updated September 4 2:33 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+23.45%

Based on its net profit margin of 23.45%, Illumina Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX1.29%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 28, 201506/28/2015Mar 29, 201503/29/2015Dec 28, 201412/28/2014Sep 28, 201409/28/2014
Revenue539539512481
Total other revenue--------
Total revenue539539512481
Gross profit376375385334
Total cost of revenue163164127147
Total operating expense387362309361
Selling / general / administrative124116122120
Research & development969214385
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4-9-8310
Other operating expenses, total----00
Operating income152176203119
Interest income (expense), net non-operating-11-11-11-11
Gain (loss) on sale of assets--------
Other--------
Income before tax141178192112
Income after tax10213715393
Income tax, total39413919
Net income10213715393
Total adjustments to net income--------
Net income before extra. items10213715393
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items10213715393
Inc. avail. to common incl. extra. items10213715393
Diluted net income10213715393
Dilution adjustment--------
Diluted weighted average shares149149149148
Diluted EPS excluding extraordinary itemsvalue per share0.690.921.030.63
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.700.870.590.69